MasKidney, Inc

Maskidney, inc email format

Verified email-pattern data for Maskidney, Inc is currently limited. You can still use the company insights and contact sections below.
At MasKidney, Inc., we are at the forefront of developing innovative treatments to tackle Autosomal Dominant Tubulointerstitial Kidney Disease (ADTKD), a debilitating condition that leads to end-stage renal disease (ESRD) in all affected patients. Affecting over 50,000 individuals in the US, ADTKD is the third most common genetic disorder of the kidney. Founded in early 2024, we are pioneering a novel gene therapy to address the critical unmet need in ADTKD, a disease for which there are no treatments to delay or prevent progression to end stage renal disease (ESRD). Our founders bring a wealth of experience and a strong commitment to advancing novel therapies in the field of kidney disease. We are driven by a shared mission to improve patient outcomes and have a positive impact in the realm of kidney health.

Company Details

Founded
-
Address
The Critical Unmet Need In Adtkd
Industry
Biotechnology Research
Looking for a particular MasKidney, Inc employee's phone or email?

Maskidney, Inc Questions

Explore related pages

Related company profiles:

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant